ARCHIVES

Sustained-Release Leuprolide Under Study In Phase III Trial.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

NCI, NHGRI Fund Two More Components of TCGA Project.

October 27, 2006

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000